← All trials
NCT00285207
Phase 2Interventional
Includes controlled clinical studies conducted to evaluate the effectiveness of the drug for a particular indication or indications in participants with the disease or condition under study and to determine the common short-term side effects and risks.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jan 1, 2006
- Primary completion
- Apr 1, 2008
- Completion date
- Jun 1, 2008
- First posted
- —
- Last posted
- —
- Enrollment
- 147
- Arms / groups
- 2 / —
- Source
- AACT · pre-existing
Sponsors
- KiraxLead sponsor
- Yeshiva UniversityOverall official - principal investigator
- University of California, IrvineOverall official - principal investigator
- Augusta UniversityOverall official - principal investigator
- Jersey Shore University Medical CenterOverall official - principal investigator
- Georgetown UniversityOverall official - principal investigator
- University of South FloridaOverall official - principal investigator
- OB/GYN Specialists of the Palm BeachesOverall official - principal investigator
- Visions Clinical ResearchOverall official - principal investigator
- Mount Vernon Clinical Research, LLCOverall official - principal investigator
- Northern California Research CorpOverall official - principal investigator
- Hope Research Institute, LLCOverall official - principal investigator
- Coastal Connecticut Research, LLCOverall official - principal investigator
- Greater Cincinnati OB/GYN, Inc.Overall official - principal investigator
- IGO Medical Group of San DiegoOverall official - principal investigator
- Hill Country OB/GYNOverall official - principal investigator
- Robin Black OGNP, Costa Mesa CaliforniaOverall official - principal investigator
- South Carolina Oncology AssociatesOverall official - principal investigator
- Office of R. Garn Mabey, MDOverall official - principal investigator
- Global OB/GYN Centers of FloridaOverall official - principal investigator
- University of OklahomaOverall official - principal investigator
- University of AlabamaOverall official - principal investigator
- University of PittsburghOverall official - principal investigator
- Physician Care Clinical Research LLCOverall official - principal investigator
- Planned ParenthoodOverall official - principal investigator
- New York Presbyterian HospitalOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.